Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes
- PMID: 8701078
Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes
Abstract
The estrogen receptor (ER) is thought to play a crucial role in the regulation of many life processes, including development, reproduction and normal physiology. Because there have been no known mutations of the estrogen receptor in normal tissue of humans and animals, its presence and tissue distribution is thought to be essential for survival. Using the techniques of homologous recombination, we have disrupted the ER gene and have produced a line of transgenic mice possessing the altered ER gene (ERKO). The mouse ER gene was disrupted by inserting a 1.8 kb PGK-Neomycin sequence into exon 2, approximately 280 bp downstream of the transcription start codon. The correct targeting of the disruption was demonstrated by Southern blot analysis and PCR. Western blot analysis of uterine preparations from ERKO females showed no detectable ER protein. Heterozygotes had one half the level of ER protein compared to wild-type animals. Estrogen insensitivity was confirmed using estrogen agonists, estradiol, hydroxy tamoxifen, diethylstilbestrol treatment for 3 days which resulted in a 3-4-fold increase in uterine wet weight and vaginal cornification in wild-type females, while ERKO mice were totally unresponsive. These data were further supported by the failure of estrogen or EGF treatment to induce DNA synthesis in uterine tissue of similarly treated mice. Lactoferrin, an estrogen-responsive gene in the uterus, was also assayed by Northern blot. Wild-type mice treated with a single estradiol injection showed a 350-fold induction in lactoferrin mRNA. while ERKO females showed no detectable response. Both male and female animals survive to adulthood with normal gross external phenotypes. As expected, females are infertile and demonstrate hypoplastic uteri and hyperemic ovaries with no apparent corpora lutea. Males are also infertile, with atrophy of the testes and seminiferous tubule dysmorphogenesis. Although the reproductive capabilities have been altered with a dramatic effect on the gonads, prenatal development of the reproductive tracts of both sexes appear to be independent of an ER-mediated response. Analysis of the mammary glands of the ERKO females at 4 months of age showed a primitive ductal rudiment rather than the fully developed ductal tree seen in wild-type siblings. Also absent were the terminal end buds seen during normal ductal morphogenesis. Both sexes show a decrease in skeletal bone density, supporting a direct role for ER action in bone. A single patient is described who is homozygous for a point mutation in the human ER gene at codon 157. The mutation produces a truncation of the ER protein and results in estrogen insensitivity syndrome. Most significant of the clinical findings are effects on skeletal bone density and retarded bone age. Findings from the patient and mice suggest that the absence of functional ER is not lethal. Mutation in the ER gene is present in the human population. Further characterization of the mice and identification of additional patients will be required to more fully understand the consequences of ER gene mutations.
Similar articles
-
Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene.Mol Endocrinol. 1995 Nov;9(11):1441-54. doi: 10.1210/mend.9.11.8584021. Mol Endocrinol. 1995. PMID: 8584021
-
A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.Cancer Res. 1999 Apr 15;59(8):1869-76. Cancer Res. 1999. PMID: 10213494
-
Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.Gynecol Oncol. 2002 Feb;84(2):271-9. doi: 10.1006/gyno.2001.6509. Gynecol Oncol. 2002. PMID: 11812086
-
Estrogen receptor knockout mice: phenotypes in the female reproductive tract.Gynecol Endocrinol. 2003 Apr;17(2):169-76. Gynecol Endocrinol. 2003. PMID: 12737678 Review.
-
Estrogen receptor null mice: what have we learned and where will they lead us?Endocr Rev. 1999 Jun;20(3):358-417. doi: 10.1210/edrv.20.3.0370. Endocr Rev. 1999. PMID: 10368776 Review.
Cited by 78 articles
-
High-Fat Diet Alters Circadian Rhythms in Mammary Glands of Pubertal Mice.Front Endocrinol (Lausanne). 2020 Jun 18;11:349. doi: 10.3389/fendo.2020.00349. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32625167 Free PMC article.
-
The genomic landscape of estrogen receptor α binding sites in mouse mammary gland.PLoS One. 2019 Aug 13;14(8):e0220311. doi: 10.1371/journal.pone.0220311. eCollection 2019. PLoS One. 2019. PMID: 31408468 Free PMC article.
-
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.Cancers (Basel). 2019 Jul 22;11(7):1028. doi: 10.3390/cancers11071028. Cancers (Basel). 2019. PMID: 31336602 Free PMC article. Review.
-
Molecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation.Front Endocrinol (Lausanne). 2019 Apr 16;10:224. doi: 10.3389/fendo.2019.00224. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31040821 Free PMC article. Review.
-
The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.Endocrinology. 2019 May 1;160(5):1097-1110. doi: 10.1210/en.2019-00015. Endocrinology. 2019. PMID: 30874767 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Other Literature Sources
-
Molecular Biology Databases